Transfer-pricing treatment of ITeS margins excludes pass-through tax recoveries and separate delayed-receivables interest after working-capital adjust...
Capacity-utilisation adjustments under TNMM can neutralise substantiated COVID-related idle costs where underutilisation materially affects profitabil...
TNMM functional comparability requires excluding rice manufacturers from a pure Basmati rice trader's benchmark and recognising operating export recei...
Working-capital adjustment subsumes delayed-receivable effects in TNMM benchmarking of captive software-development services, avoiding separate notion...
Transfer-pricing comparability requires exclusion of financially illogical super-profit comparables and correction of unsupported annual-report and ma...
Charitable character assessment preserves Section 80G approval despite inclusive spiritual teachings and incidental religious expenditure within the s...
Penalty proceedings for cash-loan acceptance require assessment proceedings and recorded Assessing Officer satisfaction; absent these, the proceedings...
Page of 4828
Press 'Enter' after typing page number.
161 to 180 of 96556 Results
❮
❯
❯❯
0 / 200
Expand Note
Add to Folder
No Folders have been created
+
Are you sure you want to delete "My most important" ?
ESOP cross-charge was held to be revenue expenditure deductible under section 37(1), as employee stock option cost represents compensation for securing and retaining employee services during the vesting period. The Tribunal followed the Special Bench ruling in Biocon Ltd. and the jurisdictional High Court's affirmation, and held that the parent company's issuance of shares did not convert the Indian entity's cross-charged liability into capital expenditure. Coordinate bench decisions supporting similar claims were also relied on. The disallowance was deleted and the assessee's deduction claim was allowed.
ESOP cross-charge was held to be revenue expenditure deductible under section 37(1), as employee stock option cost represents compensation for securing and retaining employee services during the vesting period. The Tribunal followed the Special Bench ruling in Biocon Ltd. and the jurisdictional High Court's affirmation, and held that the parent company's issuance of shares did not convert the Indian entity's cross-charged liability into capital expenditure. Coordinate bench decisions supporting similar claims were also relied on. The disallowance was deleted and the assessee's deduction claim was allowed.
Note: It is a system-generated summary and is for quick reference only.